Literature DB >> 26335771

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy.

Jorge C G Blanco1, Lioubov M Pletneva2, Raymonde O Oue2, Mira C Patel3, Marina S Boukhvalova2.   

Abstract

Respiratory Syncytial Virus (RSV) is the leading cause of pneumonia and bronchiolitis in infants, resulting in significant morbidity and mortality worldwide. There is currently no RSV vaccine. Although maternal serum antibodies against RSV are efficiently transferred through placenta protecting human infants from RSV-induced disease, this protection is short-lived and the methods for extending and augmenting protection are not known. The objective of this study was to develop an animal model of maternal RSV vaccination using the Sigmodon hispidus cotton rat. Naïve or RSV-primed female cotton rats were inoculated with live RSV and set in breeding pairs. Antibody transfer to the litters was quantified and the offspring were challenged with RSV at different ages for analysis of protection against viral replication and lung inflammation. There was a strong correlation between RSV-neutralizing antibody (NA) titers in cotton rat mothers and their pups, which also correlated with protection of litters against virus challenge. Passive protection was short-lived and strongly reduced in animals at 4 weeks after birth. Protection of litters was significantly enhanced by inoculating mothers parenterally with live RSV and inversely correlated with the expression of lung cytokines and pathology. Importantly, vaccination and boosting of naïve mothers with the live RSV produced the highest levels of NAs. We conclude that maternal vaccination against RSV in the cotton rat can be used to define vaccine preparations that could improve preexistent immunity and induce subsequent transfer of efficient immunity to infants.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cotton rat; Maternal immunization; Pregnancy; RSV

Mesh:

Substances:

Year:  2015        PMID: 26335771      PMCID: PMC5155338          DOI: 10.1016/j.vaccine.2015.08.071

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  29 in total

1.  Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.

Authors:  S Johnson; C Oliver; G A Prince; V G Hemming; D S Pfarr; S C Wang; M Dormitzer; J O'Grady; S Koenig; J K Tamura; R Woods; G Bansal; D Couchenour; E Tsao; W C Hall; J F Young
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

2.  Evolution of maternofetal transport of immunoglobulins during human pregnancy.

Authors:  A Malek; R Sager; P Kuhn; K H Nicolaides; H Schneider
Journal:  Am J Reprod Immunol       Date:  1996-11       Impact factor: 3.886

3.  Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.

Authors:  Gregory A Prince; Spencer J Curtis; Kevin C Yim; David D Porter
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

4.  Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh.

Authors:  Helen Y Chu; Mark C Steinhoff; Amalia Magaret; Khalequ Zaman; Eliza Roy; Gretchen Langdon; Mary Anne Formica; Edward E Walsh; Janet A Englund
Journal:  J Infect Dis       Date:  2014-06-05       Impact factor: 5.226

Review 5.  Maternal immunization.

Authors:  Helen Y Chu; Janet A Englund
Journal:  Clin Infect Dis       Date:  2014-05-05       Impact factor: 9.079

6.  Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.

Authors: 
Journal:  Pediatrics       Date:  1997-01       Impact factor: 7.124

7.  Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly.

Authors:  A R Falsey; E E Walsh
Journal:  Vaccine       Date:  1997-07       Impact factor: 3.641

8.  Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats.

Authors:  G A Prince; L Potash; R L Horswood; E Camargo; S C Suffin; R A Johnson; R M Chanock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection.

Authors:  Marina S Boukhvalova; Jorge C G Blanco
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants.

Authors:  J A Englund; I N Mbawuike; H Hammill; M C Holleman; B D Baxter; W P Glezen
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

View more
  12 in total

1.  Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats.

Authors:  Darren Wethington; Olivia Harder; Karthik Uppulury; William C L Stewart; Phylip Chen; Tiffany King; Susan D Reynolds; Alan S Perelson; Mark E Peeples; Stefan Niewiesk; Jayajit Das
Journal:  J R Soc Interface       Date:  2019-11-27       Impact factor: 4.118

2.  Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.

Authors:  Jorge C G Blanco; Lurds R Fernando; Wei Zhang; Arash Kamali; Marina S Boukhvalova; Lori McGinnes-Cullen; Trudy G Morrison
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

3.  Cotton Rat Placenta Anatomy and Fc Receptor Expression and Their Roles in Maternal Antibody Transfer.

Authors:  Margaret E Martinez; Stefan Niewiesk; Krista M D La Perle
Journal:  Comp Med       Date:  2020-10-29       Impact factor: 0.982

Review 4.  A multifaceted approach to RSV vaccination.

Authors:  Jorge C G Blanco; Marina S Boukhvalova; Trudy G Morrison; Stefanie N Vogel
Journal:  Hum Vaccin Immunother       Date:  2018-06-19       Impact factor: 3.452

5.  Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus).

Authors:  Mira C Patel; Wei Wang; Lioubov M Pletneva; Seesandra V Rajagopala; Yi Tan; Tina V Hartert; Marina S Boukhvalova; Stefanie N Vogel; Suman R Das; Jorge C G Blanco
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

Review 6.  Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.

Authors:  Emma Rey-Jurado; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2017-03-04       Impact factor: 5.923

7.  Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model.

Authors:  Sandra Fuentes; Laura Klenow; Hana Golding; Surender Khurana
Journal:  Sci Rep       Date:  2017-02-10       Impact factor: 4.379

8.  RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.

Authors:  Sarah Wilmschen; Sabrina Schneider; Felix Peters; Lea Bayer; Leila Issmail; Zoltán Bánki; Thomas Grunwald; Dorothee von Laer; Janine Kimpel
Journal:  Vaccines (Basel)       Date:  2019-07-03

9.  Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.

Authors:  Jorge C G Blanco; Lioubov M Pletneva; Lori McGinnes-Cullen; Raymonde O Otoa; Mira C Patel; Lurds R Fernando; Marina S Boukhvalova; Trudy G Morrison
Journal:  Nat Commun       Date:  2018-05-15       Impact factor: 14.919

Review 10.  Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.

Authors:  M S Boukhvalova; K C Yim; Jcg Blanco
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.